Stay updated on Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating an updated page version. This appears to be a metadata update rather than a substantive change to content.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check26 days agoNo Change Detected
- Check33 days agoChange DetectedThe page’s displayed software revision/version was updated from **v3.5.2** to **v3.5.3**. This indicates a general site release with no apparent change to the trial’s study details.SummaryDifference0.0%

- Check40 days agoChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check69 days agoChange DetectedAdministrative updates to the page metadata (revision v3.5.0 and EU trial identifier 2018-000096-32) were applied. There were no changes to the study details, eligibility criteria, or outcomes.SummaryDifference0.3%

- Check76 days agoChange Detected- Revision label updated from v3.4.2 to v3.4.3 across the site.SummaryDifference0.0%

- Check105 days agoChange DetectedRevision: v3.4.2 is shown, replacing v3.4.1, and the government funding notice has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab + Metronomic Chemo in Pediatric Solid Tumors Clinical Trial page.